Impaired Bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfected infants

AIDS

Volumn 25, Issue 17, 2011, Pages 2079-2087

  Mazzola, Taís N ^a   Da Silva, Marcos T N ^a   Abramczuk, Beatriz M ^a   Moreno, Yara M F ^a,b   Lima, Simone C B S ^a   Zorzeto, Tatiane Q ^a   Passeto, Andréa S Z ^a   Vilela, Maria M S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Bacillus calmette Gu rin vaccine; Cellular immunity; Cytokines; HIV seronegativity; Infant

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

AGE DISTRIBUTION; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPHENOTYPING; INFANT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; T LYMPHOCYTE;

BCG VACCINE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOPHENOTYPING; INFANT; INTERFERON-GAMMA; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MALE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80055044566     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834bba0a     Document Type: Article

References (42)

1. Thorne C, Newell M. Epidemiology of HIV infection in the newborn. Early Hum Dev 2000; 58:1-16. (Pubitemid 30227459)
2. Hawkins D, Blott M, Clayden P, de Ruiter A, Foster G, Gilling- Smith C, et al., on behalf of the BHIVA Guidelines Writing Committee. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV. HIV Med 2005; 6 (Suppl 2):107-148. (Pubitemid 41038589)
3. Amaral E, Assis-Gomes F, Milanez H, Cecatti JG, Vilela MM, Pinto E, Silva JL. Timely implementation of interventions to reduce vertical HIV transmission: a successful experience in Brazil. Rev Panam Salud Publica 2007; 21:357-364. (Pubitemid 350013908)
4. Rich KC, Siegel JN, Jennings C, Rydman RJ, Landay AL. CD4R lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy-induced immune depression in uninfected and HIV-infected women. J Infect Dis 1995; 172:1221-1227. (Pubitemid 3002582)
5. Chougnet C, Kovacs A, Baker R, Mueller BU, Luban NL, Liewehr DJ, et al. Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production. J Infect Dis 2000; 181:1590-1597. (Pubitemid 30387749)
6. Pacheco SE, McIntosh K, Lu M, Mofenson LM, Diaz C, Foca M, et al., Women and Infants Transmission Study. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: an analysis of the Women and Infants Transmission Study. J Infect Dis 2006; 194:1089-1097. (Pubitemid 44547648)
7. Ono E, Nunes dos Santos AM, de Menezes Succi RC, Machado DM, de Angelis DS, Salomaõ R, et al. Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART. Braz J Med Biol Res 2008; 41:700-708.
8. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331:1173-1180. (Pubitemid 24331334)
9. Gesner M, Papaevangelou V, Kim M, Chen S, Moore T, Krasinski K, et al. Alteration in the proportion of CD4 T lymphocytes in a subgroup of human immunodeficiency virus-exposed-uninfected children. Pediatrics 1994; 93:624-630. (Pubitemid 24106610)
10. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000; 96:3866-3871.
11. Silva EB, Grotto HZW, Vilela MMS. Clinical aspects and complete blood counts in children exposed to HIV-1: comparison between infected patients and seroreverters. J Pediatr (Rio J) 2001; 77:503-511.
12. Le Chenadec J, Mayaux MJ, Guihenneuc-Jouyaux C, Blanche S, Enquête Périnatale Française Study Group. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS 2003; 17:2053-2061. (Pubitemid 37297153)
13. Bunders M, Cortina-Borja M, Kuijpers TW, Newell ML, for the European Collaborative Study. Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1- infected mothers. AIDS 2004; 18:2009-2017. (Pubitemid 39463354)
14. Bunders MJ, Bekker V, Scherpbier HJ, Boer K, Godfried M, Kuijpers TW. Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers. Acta Paediatr 2005; 94:1571-1577. (Pubitemid 41754310)
15. Bunders M, Thorne C, Newell ML, for the European Collaborative Study. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS 2005; 19:1071-1079. (Pubitemid 40961148)
16. El Beitune PE, Duarte G. Antiretroviral agents during pregnancy: consequences on hematologic parameters in HIV-exposed, uninfected newborn infant. Eur J Obstet Gynecol Reprod Biol 2006; 128:59-63. (Pubitemid 44311346)
17. Rich KC, Siegel JN, Jennings C, Rydman RJ, Landay AL. Function and phenotype of immature CD4R lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol 1997; 4:358-361. (Pubitemid 27239698)
18. Miyamoto M, Pessoa SD, Ono E, Machado DM, Salomaõ R, Succi RC, et al. Low CD4R T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents. J Trop Pediatr 2010; 56:427-432.
19. Jackson KM, Nazar AM. Breastfeeding, the immuneresponse, and long-term health. J Am Osteopath Assoc 2006; 106:203-207.
20. Moraes-Pinto MI, Verhoeff F, Chimsuku L, Milligan PJM, Wesumperuma L, Broadhead RL, et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed 1998; 79:F202-F205. (Pubitemid 28500677)
21. Hesseling AC, Cotton MF, Fordham von Reyn C, Graham SM, Gie RP, Hussey GD. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants. Int J Tuberc Lung Dis 2008; 12:1376-1379.
22. World Health Organization. Global tuberculosis control: WHO report 2010. Geneva, Switzerland: WHO Press; 2010.
23. Borkowsky W, Rigaud M, Krasinski K, Moore T, Lawrence R, Pollack H. Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life. J Pediatr 1992; 120:371-375.
24. Ota MOC, O'Donovan D, Marchant A, Yamuah L, Harding E, Jaffara S, et al. HIV-negative infants born to HIV-1 but not HIV- 2-positive mothers fail to develop a Bacillus Calmette-Guérin scar. AIDS 1999; 13:996-998. (Pubitemid 29240199)
25. Mazzola TN, Da Silva MT, Moreno YM, Lima SC, Carniel EF, Morcillo AM, et al. Robust gdR T cell expansion in infants immunized at birth with BCG vaccine. Vaccine 2007; 25:6313-6620.
26. World Health Organization. WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weightfor- height and body mass index-for-age: methods and development. Geneva, Switzerland: WHO Press; 2006.
27. Centers for Disease Control. BCG vaccination and pediatric HIV infection: Rwanda, 1988-1990. MMWR Morb Mortal Wkly Rep 1991; 40:833-836.
28. Miles DJ,GadamaL,Gumbi A,Nyalo F,Makanani B,Heyderman RS. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIVuninfected infants. Immunology 2009; 129:446-454.
29. Wasik TJ, Bratosiewicz J, Wierzbicki A, Whiteman VE, Rutstein RR, Starr SE, et al. Protective role of b-chemokines associated with HIV-specific Th responses against perinatal HIV transmission. J Immunol 1999; 62:4355-4364. (Pubitemid 29314829)
30. Van Rie A, Madhi SA, Heera JR, Meddows-Taylor S, Wendelboe AM, Anthony F, et al. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers. Clin Vaccine Immunol 2006; 13:246-252. (Pubitemid 43383794)
31. Mansoor N, Scriba TJ, de Kock M, Tameris M, Abel B, Keyser A, et al. HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine. J Infect Dis 2009; 199:982-990.
32. Kuhn L, Coutsoudis A, Moodley D, Mngqundaniso N, Trabattoni D, Shearer GM, et al. Interferon-gamma and interleukin- 10 production among HIV-1-infected and uninfected infants of HIV-1-infected mothers. Pediatr Res 2001; 50:412-416. (Pubitemid 32801968)
33. Pabst HF, Godel J, Grace M, Cho H, Spady DW. Effect of breastfeeding on immune response to BCG vaccination. Lancet 1989; 1:295-297. (Pubitemid 19049404)
34. Hahn-Zoric M, Fulconis F, Minoli I, Moro G, Carlsson B, Bottiger M, et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatr Scand 1990; 79:1137-1142.
35. Pabst HF, Spady DW. Effect of breast-feeding on antibody response to conjugate vaccine. Lancet 1990; 336:269-270. (Pubitemid 20229122)
36. Vesikari T, Ruuska T, Delem A, Andre FE. Oral rotavirus vaccination in breast- and bottle-fed infants aged 6 to 12 months. Acta Paediatr Scand 1986; 75:573-578. (Pubitemid 16100484)
37. Scheifele D, Bjornson GJ, Guasparini R, Friesen B, Meekison W. Breastfeeding and antibody responses to routine vaccination in infants. Lancet 1992; 340:1406.
38. Mbori-Ngacha D, Nduati R, John G, Reilly M, Richardson B, Mwatha A, et al. Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: a randomized clinical trial. JAMA 2001; 286:2413-2420. (Pubitemid 33098159)
39. Slogrove AL, Cotton MF, Esser MM. Severe infections in HIVexposed uninfected infants: clinical evidence of immunodeficiency. J Trop Pediatr 2010; 56:75-81.
40. Kuhn L, Meddows-Taylor S, Gray G, Tiemessen C. Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero. Clin Infect Dis 2002; 34:267-276. (Pubitemid 34028361)
41. Hygino J, Lima PG, Filho RG, Silva AA, Saramago CS, Andrade RM, et al. Altered immunological reactivity in HIV-1-exposed uninfected neonates. Clin Immunol 2008; 127:340-347.
42. Faye A, Pornprasert S, Mary JY, Dolcini G, Derrien M, Barré - Sinoussi F, et al. Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with antiretroviral drugs in France. Clin Exp Immunol 2007; 149:430-439. (Pubitemid 47256145)